VanDevanter, D., Yegin, A., Morgan, W., Millar, S., Pasta, D., & Konstan, M. (2011). DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING PULMONARY EXACERBATION AS AN EFFICACY ENDPOINT.
Chicago ZitierstilVanDevanter, DR, A. Yegin, WJ Morgan, SJ Millar, DJ Pasta, und MW Konstan. DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING PULMONARY EXACERBATION AS AN EFFICACY ENDPOINT. 2011.
MLA ZitierstilVanDevanter, DR, et al. DESIGN AND POWERING OF CYSTIC FIBROSIS CLINICAL TRIALS USING PULMONARY EXACERBATION AS AN EFFICACY ENDPOINT. 2011.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.